Oncternal Therapeutics Stock Forecast - Accumulation Distribution
| ONCT Stock | USD 8.60 0.06 0.69% |
Oncternal Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Oncternal Therapeutics stock prices and determine the direction of Oncternal Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Oncternal Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Oncternal Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Oncternal Therapeutics' systematic risk associated with finding meaningful patterns of Oncternal Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Oncternal Therapeutics to cross-verify your projections. Oncternal |
Open Interest Against 2024-07-19 Oncternal Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Oncternal Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Oncternal Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Oncternal Therapeutics stock based on available contracts left at the end of a trading day.
No Open InterestPlease note that to derive more accurate forecasting about market movement from the current Oncternal Therapeutics' open interest, investors have to compare it to Oncternal Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Oncternal Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Oncternal. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Oncternal Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Oncternal Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Oncternal Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
The accumulation distribution (A/D) indicator shows the degree to which Oncternal Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Oncternal Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Oncternal Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 0.0458 | 0.0458 |
| Check Oncternal Therapeutics Volatility | Backtest Oncternal Therapeutics | Information Ratio |
Oncternal Therapeutics Trading Date Momentum
| On May 21 2024 Oncternal Therapeutics was traded for 8.60 at the closing time. The top price for the day was 8.95 and the lowest listed price was 8.54 . There was no trading activity during the period 0.0. Lack of trading volume on May 21, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.70% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Oncternal Therapeutics to competition |
Other Forecasting Options for Oncternal Therapeutics
For every potential investor in Oncternal, whether a beginner or expert, Oncternal Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oncternal Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oncternal. Basic forecasting techniques help filter out the noise by identifying Oncternal Therapeutics' price trends.View Oncternal Therapeutics Related Equities
| Risk & Return | Correlation |
Oncternal Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Oncternal Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Oncternal Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Oncternal Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Oncternal Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncternal Therapeutics shares will generate the highest return on investment. By undertsting and applying Oncternal Therapeutics stock market strength indicators, traders can identify Oncternal Therapeutics entry and exit signals to maximize returns.
Oncternal Therapeutics Risk Indicators
The analysis of Oncternal Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oncternal Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncternal stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.1 | |||
| Standard Deviation | 4.01 | |||
| Variance | 16.06 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
When determining whether Oncternal Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Oncternal Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Oncternal Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Oncternal Therapeutics Stock: Check out Historical Fundamental Analysis of Oncternal Therapeutics to cross-verify your projections. For more information on how to buy Oncternal Stock please use our How to Invest in Oncternal Therapeutics guide.Note that the Oncternal Therapeutics information on this page should be used as a complementary analysis to other Oncternal Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Oncternal Stock analysis
When running Oncternal Therapeutics' price analysis, check to measure Oncternal Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncternal Therapeutics is operating at the current time. Most of Oncternal Therapeutics' value examination focuses on studying past and present price action to predict the probability of Oncternal Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncternal Therapeutics' price. Additionally, you may evaluate how the addition of Oncternal Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Oncternal Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncternal Therapeutics. If investors know Oncternal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncternal Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.33) | Revenue Per Share 0.39 | Quarterly Revenue Growth 1.803 | Return On Assets (0.49) | Return On Equity (0.87) |
The market value of Oncternal Therapeutics is measured differently than its book value, which is the value of Oncternal that is recorded on the company's balance sheet. Investors also form their own opinion of Oncternal Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Oncternal Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncternal Therapeutics' market value can be influenced by many factors that don't directly affect Oncternal Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncternal Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncternal Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncternal Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.